Muscle‐specific kinase (MuSK) antibody‐associated myasthenia gravis after bone marrow transplantation

Baron F, 1998, Myasthenia gravis without chronic GVHD after allogenic bone marrow transplantation, Bone Marrow Transplant, 2, 197, 10.1038/sj.bmt.1701297

10.1002/mus.20854

10.1212/01.wnl.0000254620.45529.97

10.1038/sj.bmt.1702067

10.1093/brain/awg223

10.1212/01.wnl.0000183145.91579.74

10.1002/mus.880171208

10.1034/j.1600-0609.2002.02789.x

10.1111/j.1749-6632.1987.tb51382.x

10.1038/sj.bmt.1700759

Sanders DB, 2003, Clinical aspects of MuSK antibody positive seronegative MG, Neurology, 60, 1078, 10.1212/01.WNL.0000065882.63904.53

10.1097/01.LAB.0000028144.48023.9B

10.1056/NEJM198312223092508

10.1016/S0140-6736(85)91742-8

10.1038/sj.bmt.1701575

Yanagihara C, 2001, A patient of chronic graft‐versus‐host disease presenting simultaneously with polymyositis and myasthenia gravis, Rinsho Shinkeigaku, 41, 503

Zhao L, 2004, Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and negative myasthenic patients, Muscle Nerve, 30, 55, 10.1002/mus.20069